内藤 俊夫 ないとう としお 先生

来歴等

略歴

1994年 順天堂大学医学部附属順天堂医院 内科 臨床研修医
1997年 順天堂大学医学部総合診療科研究室 専攻生
1998年 東京医科歯科大学医学部 微生物学教室 研究生
2000年 米国テンプル大学 神経ウイルス学・癌生物学センター 留学（助手）
2002年 順天堂大学医学部 総合診療科研究室 助手
2003年 順天堂大学医学部 総合診療科研究室 講師
2007年 順天堂大学医学部 総合診療科研究室 准教授
2008年 米国メイヨークリニック 感染症科 留学
2013年 順天堂大学医学部 総合診療科研究室 先任准教授
2013年 聖マリアンナ医科大学 総合診療科内科 客員教授
2015年 順天堂大学医学部 総合診療科研究室 教授
2018年 順天堂大学医学部 総合診療科学講座 教授

論文

1. Emoto M, Naito T, Nakamura R, Yoshikai Y. Different appearance of gamma delta T cells during salmonellosis between Ityr and Itys mice. J Immunol. 1993;150(8 Pt 1):3411-20.
2. Naito T, Matsuyama S, Ogawa K, Sekigawa I, Iida N, Shimizu K, et al. Ulcerative colitis associated with autoimmune progesterone dermatitis. J Clin Gastroenterol. 1997;25(2):488-9.
3. Naito T, Takeda-Hirokawa N, Kaneko H, Sekigawa I, Matsumoto T, Hashimoto H, et al. Role of curdlan sulfate in the production of beta-chemokines and interleukin-16. Med Microbiol Immunol. 1998;187(1):43-8.
4. Kaneko H, Ogasawara H, Naito T, Akimoto H, Lee S, Hishikawa T, et al. Circulating levels of beta-chemokines in systemic lupus erythematosus. J Rheumatol. 1999;26(3):568-73.
5. Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. J Hum Virol. 2001;4(6):306-16.
6. Naito T, Okada M, Ogasawara H, Kaneko H, Hishikawa T, Matsumoto T, et al. Curdlan sulfate induces the downmodulation of chemokine receptors leading to suppression of HIV infection. J Acquir Immune Defic Syndr. 2001;26(5):512-3.
7. Ogasawara H, Naito T, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, et al. Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol. 2001;28(3):533-8.
8. Kiszka I, Kmieciak D, Gzyl J, Naito T, Bolesta E, Sieron A, et al. Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates. J Virol. 2002;76(9):4222-32.
9. Naito T, Sekigawa I, Takeda N, Ebe T, Sekiya S, Isonuma H, et al. The Relationship between IgE level and HIV Viral Load. General Medicine. 2002;3(1):17-8.
10. Sekigawa I, Okada M, Ogasawara H, Naito T, Kaneko H, Hishikawa T, et al. Lessons from similarities between SLE and HIV infection. J Infect. 2002;44(2):67-72.
11. Naito T, Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, et al. Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J Clin Immunol. 2003;23(5):371-6.
12. Sekigawa I, Ogasawara H, Naito T, Kaneko H, Hishikawa T, Hashimoto H. Systemic lupus erythematosus and human endogenous retroviruses. Mod Rheumatol. 2003;13(2):107-13.
13. Gzyl J, Bolesta E, Wierzbicki A, Kmieciak D, Naito T, Honda M, et al. Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses. Virology. 2004;318(2):493-506.
14. Kukino J, Naito T, Mitsuhashi K, Oshima H, Sekiya S, Isonuma H, et al. Susceptibility of medical students to vaccine-preventable viral diseases: a serological study. J Infect Chemother. 2004;10(6):335-7.
15. Naito T, Sakamoto N, Okumura T, Isonuma H, Fukutome A, Dambara T, et al. Analysis of the patients transferred by helicopter from the clinic of an isolated island. JJSAS. 2004;5(1):36-8.
16. Okumura T, Hisaoka H, Yamada A, Okumura S, Tomita Y, Naito T, et al. Poisoning due to house furnishings. Clinic All-round. 2004;53:1227-30.
17. Sekigawa I, Naito T, Hira K, Mitsuishi K, Ogasawara H, Hashimoto H, et al. Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus. 2004;13(4):217-22.
18. Ikeda N, Naito T, Isonuma H, Dambara T, Hayashida Y. Polycystic Kidney Complicated by Cholangiocellular Carcinoma Presenting as Fever of Unknown Origin. General Medicine. 2005;6(1):23-7.
19. Ogasawara H, Inui A, Tanaka C, Kaneko H, Naito T, Sekigawa I, et al. The abnormality of DNA methylation in patients with SLE. Modern Rheumatology. 2005;15:108.
20. Okumura S, Okumura T, Ishimatsu S, Miura K, Maekawa H, Naito T. Clinical review: Tokyo - protecting the health care worker during a chemical mass casualty event: an important issue of continuing relevance. Crit Care. 2005;9(4):397-400.
21. Okumura T, Hisaoka T, Naito T, Isonuma H, Okumura S, Miura K, et al. Acute and chronic effects of sarin exposure from the Tokyo subway incident. Environ Toxicol Pharmacol. 2005;19(3):447-50.
22. Okumura T, Hisaoka T, Yamada A, Naito T, Isonuma H, Okumura S, et al. The Tokyo subway sarin attack--lessons learned. Toxicol Appl Pharmacol. 2005;207(2 Suppl):471-6.
23. Naito T, Fukuda Y, Inui A, Takeda N, Isonuma H, Dambara T, et al. Malignant Lymphoma of the Ileum. General Medicine. 2006;7(1):35-6.
24. Naito T, Fukuda Y, Matsumoto N, Takeda N, Dambara T, Hayashida Y. A gallium scintigraphy of fever of unknown origin. Intern Med. 2006;45(11):743.
25. Naito T, Kudo N, Hada N, Shiga T, Inui A, Ikeda N, et al. Acute Retroviral Syndrome Presenting as Infectious Mononucleosis. General Medicine. 2006;7(2):77-80.
26. Naito T, Kudo N, Ikeda N, Takeda N, Dambara T, Hayashida Y. A foreign body in the duodenum. Intern Med. 2006;45(7):491-2.
27. Naito T, Kudo N, Inui A, Matsumoto N, Takeda N, Isonuma H, et al. Causes of infectious mononucleosis-like syndrome in adult patients. Intern Med. 2006;45(13):833-4.
28. Naito T, Kume K, Mitsuhashi K, Okumura T, Isonuma H, Dambara T, et al. Overwhelming Pneumococcal Infection Due to Congenital Hyposplenism or Asplenia in Adults. General Medicine. 2006;7(1):21-4.
29. Yamamoto N, Tanaka C, Wu Y, Chang MO, Inagaki Y, Saito Y, et al. Analysis of Human Immunodeficiency Virus Type 1 Integration by Using A Specific, Sensitive and Quantitative Assay Based on Real-time Polymerase Chain Reaction. Virus Genes. 2006;32(1):105-13.
30. Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, et al. Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol. 2007;26(10):1675-8.
31. Naito T, Inui A, Kudo N, Matsumoto N, Fukuda H, Isonuma H, et al. Seroprevalence of IgG anti-toxoplasma antibodies in asymptomatic patients infected with human immunodeficiency virus in Japan. Intern Med. 2007;46(14):1149-50.
32. Naito T, Kaneko Y, Kozbor D. Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization. J Gen Virol. 2007;88(Pt 1):61-70.
33. Naito T, Kudo N, Hattori M, Watanabe Y, Matsumoto N, Isonuma H, et al. Toxoplasma Encephalitis in a HIV-infected Patient. General Medicine. 2007;8(1):29-30.
34. Naito T, Saita M, Shiga T, Kudo N, Hada N, Inui A, et al. Deep Venous Thrombosis Caused by a Femoral Venous Catheter. General Medicine. 2007;8(1):31-2.
35. Sugihara E, Dambara T, Aiba M, Fukuda Y, Nakajima N, Inui A, et al. [Clinical study on lung disease caused by non-tuberculous mycobacteriosis in the elderly]. Nihon Ronen Igakkai Zasshi. 2007;44(4):503-6.
36. Sugihara E, Dambara T, Aiba M, Okamoto M, Yonemitsu J, Sonobe S, et al. Clinical characteristics of 8 sporadic cases of community-acquired Legionella pneumonia in advanced age. Intern Med. 2007;46(8):461-5.
37. Fukumura Y, Masaoka A, Naito T, Kimura M, Yao T. A case of non-invasive serous adenocarcinoma at unilateral fimbria with spread to the peritoneal/uterine cavity: case report. Diagn Pathol. 2009;4:43-6.
38. Naito T, Saita M, Misawa S, Nakamura A, Isonuma H, Kondo S, et al. Cyclospora infection in an immunocompetent patient in Japan. Jpn J Infect Dis. 2009;62(1):57-8.
39. Ohba K, Ryo A, Dewan MZ, Nishi M, Naito T, Qi X, et al. Follicular dendritic cells activate HIV-1 replication in monocytes/macrophages through a juxtacrine mechanism mediated by P-selectin glycoprotein ligand 1. J Immunol. 2009;183(1):524-32.
40. Saita M, Naito T, Katayama A, Fukuda H, Isonuma H, Dambara T. Prevalence of Treponema pallidum, Hepatitis B Virus and Hepatitis C Virus Infection in Non-hemophiliac Patients Infected with Human Immunodeficiency Virus in Japan. J AIDS Res. 2010;12(1):28-33.
41. Sugihara E, Naito T, Aiba M, Matsuda N, Shiga T, Amari Y, et al. A Case of Synovitis Acne Pustulosis Hyperostosis Osteitis (SAPHO) Syndrome. General Medicine. 2010;11(2):91-2.
42. Inui A, Naito T, Sugihara E, Isonuma H. A Case of Paragonimus westermani Infection Diagnosed by Serological Testing. General Medicine. 2011;12(1):19-23.
43. Saita M, Naito T, Boku S, Watanabe Y, Suzuki M, Oka F, et al. The efficacy of ma-huang-tang (maoto) against influenza. Health. 2011;03(05):300-3.
44. Watanabe Y, Naito T, Kikuchi K, Amari Y, Uehara Y, Isonuma H, et al. Infective endocarditis with Lactococcus garvieae in Japan: a case report. J Med Case Rep. 2011;5:356-9.
45. Oike M, Naito T, Tsukada M, Kikuchi Y, Sakamoto N, Otsuki Y, et al. A case of diaphragmatic paralysis complicated by herpes-zoster virus infection. Intern Med. 2012;51(10):1259-63.
46. Oka F, Naito T, Oike M, Imai R, Saita M, Inui A, et al. Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan. J Infect Chemother. 2012;18(1):17-21.
47. Boku S, Naito T, Murai K, Tanei M, Inui A, Nisimura H, et al. Near point-of-care administration by the attending physician of the rapid influenza antigen detection immunochromatography test and the fully automated respiratory virus nucleic acid test: contribution to patient management. Diagn Microbiol Infect Dis. 2013;76(4):445-9.
48. Naito T. An initiative offering free pneumococcal vaccination to victims of the Great East Japan earthquake. Thorax. 2013;68(11):1068-9.
49.Naito T, Mizooka M, Mitsumoto F, Kanazawa K, Torikai K, Ohno S, et al. Diagnostic workup for fever of unknown origin: a multicenter collaborative retrospective study. BMJ Open. 2013;3(12):e003971.
50. Nishijima T, Gatanaga H, Shimbo T, Komatsu H, Endo T, Horiba M, et al. Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial. PLoS One. 2013;8(8):e73639.
51. Nishijima T, Takano M, Ishisaka M, Komatsu H, Gatanaga H, Kikuchi Y, et al. Abacavir/lamivudine versus tenofovir/emtricitabine with atazanavir/ritonavir for treatment-naive Japanese patients with HIV-1 infection: a randomized multicenter trial. Intern Med. 2013;52(7):735-44.
52. Oka F, Naito T, Oike M, Saita M, Inui A, Uehara Y, et al. Influence of smoking on HIV infection among HIV-infected Japanese men. J Infect Chemother. 2013;19(3):542-4.
53. Sakurai T, Watanabe Y, Inui A, Oshima H, Isonuma H, Dambara T, et al. A case of human fascioliasis infected from eating watercress in Japan. J Hosp Gen Med. 2013;5(2):62-6.
54. Yanagawa Y, Aihara K, Watanabe S, Takemoto M, Naito T, Iba T, et al. Whole Body CT for a Patient with Sepsis. World Academy of Science, Engineering and Technology. 2013;7(6):318-21.
55. Amari Y, Uehara Y, Watanabe Y, Inui A, Sugihara E, Yokokawa H, et al. Status of antimicrobial use among dentists in Japan. J Hosp Gen Med. 2014;6(1):8-15.
56. Naito T, Matsuda N, Tanei M, Watanabe Y, Watanabe A. Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the free vaccination campaign after the Great East Japan Earthquake. J Infect Chemother. 2014;20(7):450-3.
57. Suzuki M, Inui A, Sakurai T, Mitsuhashi K, Isonuma H, Dambara T, et al. A case of Vibrio cholerae 01 infection in Japan with no history of recent travel to cholera-endemic areas. J Hosp Gen Med. 2014;7(1):23-5.
58. Takahashi H, Tsubouchi A, Murai K, Yamanouchi M, Tanei M, Sakamoto R, et al. Seroprevalence of Toxoplasma gondii Infection among HIV-Infected Patients in Tokyo, Japan. Journal of HIV/AIDS & Social Services. 2014;1:1007-10.
59. Tanei M, Yokokawa H, Murai K, Sakamoto R, Amari Y, Boku S, et al. Factors influencing the diagnostic accuracy of the rapid influenza antigen detection test (RIADT): a cross-sectional study. BMJ Open. 2014;4(1):e003885.
60. Yamanouchi M, Uehara Y, Yokokawa H, Hosoda T, Watanabe Y, Shiga T, et al. Analysis of 256 cases of classic fever of unknown origin. Intern Med. 2014;53(21):2471-5.
61. Fu CJ, Kao CY, Lee YL, Liao CW, Chen PC, Chuang TW, et al. Seroprevalence and Associated Risk Factors of Toxocariasis among College Students in Taipei City, Taiwan. Iran J Parasitol. 2015;10(3):482-9.
62. Goto Y, Yokokawa H, Fukuda H, Naito T, Hisaoka T, Isonuma H. Body mass index and waist circumference are independent risk factors for low vital capacity among Japanese participants of a health checkup: a single-institution cross-sectional study. Environ Health Prev Med. 2015;20(2):108-15.
63. Hung CS, Su HW, Lee YL, Weng HW, Wang YC, Naito T, et al. Seroprevalence, Seroconversion, and Risk Factors for Toxoplasmosis among Pregnant Women in Taipei, Taiwan. Jpn J Infect Dis. 2015;68(4):312-7.
64. Naito T, Torikai K, Mizooka M, Mitsumoto F, Kanazawa K, Ohno S, et al. Relationships between Causes of Fever of Unknown Origin and Inflammatory Markers: A Multicenter Collaborative Retrospective Study. Intern Med. 2015;54(16):1989-94.
65. Fujibayashi K, Gunji T, Yokokawa H, Naito T, Sasabe N, Okumura M, et al. The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men. PLoS One. 2016;11(3):e0149689.
66. Fujibayashi K, Hayashi M, Yokokawa H, Naito T. Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan. Diabetol Metab Syndr. 2016;8:72.
67. Fukui S, Uehara Y, Fujibayashi K, Takahashi O, Hisaoka T, Naito T. Bacteraemia predictive factors among general medical inpatients: a retrospective cross-sectional survey in a Japanese university hospital. BMJ Open. 2016;6(7):e010527.
68. Hosoda T, Uehara Y, Matsuda N, Kawase Y, Tanei M, Haba Y, et al. Performance Evaluation of a Novel Fully Automated Real-Time Reverse Transcriptase-Polymerase Chain Reaction Kit for the Detection of Norovirus. Rinsho Byori. 2016;64(12):1347-52.
69. Inui A, Naito T. A Case of IgG4-Related Disease Admitted with CRP Elevation of Unknown Origin. Juntendo Medical Journal. 2016;62(3):228-31.
70. Kudo N, Yokokawa H, Fukuda H, Hisaoka T, Isonuma H, Naito T. Analysis of Associations between Health Literacy and Healthy Lifestyle Characteristics among Japanese Outpatients with Lifestyle-related Disorders. Journal of General and Family Medicine. 2016;17(4):299-306.
71. Liao CW, Fu CJ, Kao CY, Lee YL, Chen PC, Chuang TW, et al. Prevalence of intestinal parasitic infections among school children in capital areas of the Democratic Republic of São Tomé and Príncipe, West Africa. Afr Health Sci. 2016;16(3):690-7.
72. Morita F, Kano M, Uehara Y, Aoki M, H Stein G, Naito T. Dr. Stein’s Problem-Based Learning. Juntendo Medical Journal. 2016;62(2):88-95.
73. Naito T. Should Inflammatory Markers Be Used in the Diagnosis of a Fever of Unknown Origin? Intern Med. 2016;55(10):1407.
74. Naito T. Clinical Approach to Febrile Patients. Juntendo Medical Journal. 2016;62(3):224-7.
75. Okamoto A, Yokokawa H, Sanada H, Naito T. Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients. Drugs R D. 2016;16(3):255-61.
76. Suzuki A, Uehara Y, Saita M, Inui A, Isonuma H, Naito T. Raltegravir and Abacavir/Lamivudine in Japanese Treatment-Naïve and Treatment-Experienced Patients with HIV Infection: a 48-Week Retrospective Pilot Analysis. Jpn J Infect Dis. 2016;69(1):33-8.
77. Suzuki K, Hirai Y, Morita F, Uehara Y, Oshima H, Mitsuhashi K, et al. A case of infective endocarditis along with a ruptured valve caused by Streptococcus agalactiae in an immunocompetent man. IDCases. 2016;6:94-6.
78. Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T, Uehara Y, et al. Association Between Serum Uric Acid Levels/Hyperuricemia and Hypertension Among 85,286 Japanese Workers. J Clin Hypertens (Greenwich). 2016;18(1):53-9.
79. Yokokawa H, Fukuda H, Yuasa M, Sanada H, Hisaoka T, Naito T. Association between health literacy and metabolic syndrome or healthy lifestyle characteristics among community-dwelling Japanese people. Diabetol Metab Syndr. 2016;8:30.
80. Haba Y, Oshima H, Naito T, Takasu K, Ishimaru F. Upper-extremity Deep Vein Thrombosis Complicating Apheresis in a Healthy Donor. Intern Med. 2017;56(13):1739-43.
81. Kobayashi T, Yokokawa H, Fujibayashi K, Haniu T, Hisaoka T, Fukuda H, et al. Association between high cystatin C levels and carotid atherosclerosis. World J Cardiol. 2017;9(2):174-81.
82. Miyagami T, Yokokawa H, Fujibayashi K, Gunji T, Sasabe N, Okumura M, et al. The waist circumference-adjusted associations between hyperuricemia and other lifestyle-related diseases. Diabetol Metab Syndr. 2017;9:1-8.
83. Morita F, Hirai Y, Suzuki K, Uehara Y, Mitsuhashi K, Amano A, et al. Infective endocarditis and Sjögren's syndrome diagnosed simultaneously. IDCases. 2017;7:6-8.
84. Morita F, Hirai Y, Suzuki K, Uehara Y, Mitsuhashi K, Takahashi M, et al. The First Case of Pseudomonas aeruginosa Bacteremic Pneumonia in a Cancer Patient Receiving Pegfilgrastim. Intern Med. 2017;56(15):2039-42.
85. Morita F, Yokokawa H, Matsuda N, Fujibayashi K, Uehara Y, Kobayashi H, et al. Comparative efficacy of goreisan and probiotics in Japanese adults with acute infectious gastroenteritis: Randomized controlled trial. Traditional & Kampo Medicine. 2017;4(2):89-93.
86. Suzuki K, Hirai Y, Morita F, Nakamura A, Uehara Y, Naito T. Streptobacillus moniliformis Bacteremia in a Pet Shop Employee: Case Report and Literature Review. Open Forum Infect Dis. 2017;4(2):1-3.
87. Abe N, Inui A, Yokokawa H, Naito T. Retrospective study of the change in vaccination rate through the introduction of regular pneumococcal vaccination and a check box. J Hosp Gen Med. 2018;14(4):275-83.
88. Fujibayashi K, Takahashi H, Tanei M, Uehara Y, Yokokawa H, Naito T. A New Influenza-Tracking Smartphone App (Flu-Report) Based on a Self-Administered Questionnaire: Cross-Sectional Study. JMIR Mhealth Uhealth. 2018;6(6):e136.
89. Haba Y, Seo E, Akizuki H, Kato N, Watanabe S, Naito T. A Case of Severe Skin Eruption and Weakness Associated with Topical Indomethacin Treatment. J Hosp Gen Med. 2018;14(5):508-13.
90. Hosoda T, Uehara Y, Fujibayashi K, Yokokawa H, Kobayashi K, Sakamoto N, et al. Reduction of adverse effects by low-dose intravenous pentamidine for HIV-associated Pneumocystis jirovecii pneumonia. J Hosp Gen Med. 2018;14(5):484-92.
91. Maeta K, Nishiyama Y, Fujibayashi K, Gunji T, Sasabe N, Iijima K, et al. Prediction of Glucose Metabolism Disorder Risk Using a Machine Learning Algorithm: Pilot Study. JMIR Diabetes. 2018;3(4):e10212.
92. Naito T, Fukui-Watanabe Y, Uehara Y, Aoki M, H Stein G. Dr. Stein’s Problem-Based Learning “I Can’t Walk Because of Fever and Physical Pain!”. Juntendo Medical Journal. 2018;64(5):338-43.
93. Naito T, Yokokawa H, Watanabe A. Impact of the national routine vaccination program on 23-valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan. J Infect Chemother. 2018;24(6):496-8.
94. Nakamura N, Uehara Y, Fukui S, Fujibayashi K, Yokokawa H, Naito T. Useful Predictive Factors for Bacteremia among Outpatients with Pyelonephritis. Intern Med. 2018;57(10):1399-403.
95. Nakano F, Ueno Y, Suda A, Takanashi M, Yamashita A, Abe Y, et al. Fatal ischemic stroke caused by cerebral small arteritis in a patient with giant cell arteritis. J Neurol Sci. 2018;391:22-4.
96. Ruzicka DJ, Imai K, Takahashi K, Naito T. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database. BMJ Open. 2018;8(6):1-10.
97. Yanagisawa N, Muramatsu T, Koibuchi T, Inui A, Ainoda Y, Naito T, et al. Prevalence of Chronic Kidney Disease and Poor Diagnostic Accuracy of Dipstick Proteinuria in Human Immunodeficiency Virus-Infected Individuals: A Multicenter Study in Japan. Open Forum Infect Dis. 2018;5(10):ofy216.
98. Abe T, Kushimoto S, Tokuda Y, Phillips GS, Rhodes A, Sugiyama T, et al. Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: a descriptive analysis of a prospective observational study. Crit Care. 2019;23(1):360.
99. Fukushima S, Suzuki M, Abe N, Shimada Y, Ohno M, Yokokawa H, et al. Impact of the Introduction of a Vaccination Status Checkbox in Electronic Medical Records on Pneumococcal Vaccination Rates. Juntendo Medical Journal. 2019;65(1):92-4.
100. Haba Y, Shiga T, Naito T. Acute Exacerbation of Fever Following Administration of Tropicamide and Phenylephrine Ophthalmic Solution: A Case Report. Drug Saf Case Rep. 2019;6(1):2-5.
101. Haba Y, Tomyo R, Naito T. A Case of Good's Syndrome Accompanied by Agammaglobulinemia and Diarrhea. J Hosp Gen Med. 2019;1(3):31-5.
102. Katayama A, Yokokawa H, Fukuda H, Ono Y, Isonuma H, Hisaoka T, et al. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout. Intern Med. 2019;58(9):1225-31.
103. Kimura K, Tabe Y, Ai T, Takehara I, Fukuda H, Takahashi H, et al. A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA. Sci Rep. 2019;9(1):13385.
104. Matsuda N, Murai K, Sakama R, Asahina M, Fukumura Y, Yao T, et al. Rosai-Dorfman disease with paratracheal adenopathy presenting as a fever of unknown origin(FUO). J Hosp Gen Med. 2019;15(1):1-7.
105. Naito T, Tanei M, Ikeda N, Ishii T, Suzuki T, Morita H, et al. Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study. BMJ Open. 2019;9(11):e032059.
106. Nojiri S, Itoh H, Kasai T, Fujibayashi K, Saito T, Hiratsuka Y, et al. Comorbidity status in hospitalized elderly in Japan: Analysis from National Database of Health Insurance Claims and Specific Health Checkups. Sci Rep. 2019;9(1):20237.
107. Ruzicka DJ, Imai K, Takahashi K, Naito T. Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study. Journal of Infection and Chemotherapy. 2019;25(2):89-95.
108. Ruzicka DJ, Kuroishi N, Oshima N, Sakuma R, Naito T. Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database. BMC Infect Dis. 2019;19(1):505.
109. Sakama R, Yokokawa H, Fujibayashi K, Naito T, Sato Y, Yamanaka C, et al. Psychological Characteristics of Children at Two Years after the Great East Japan Earthquake: Analyses of Telephone Consultation Records. Tohoku J Exp Med. 2019;249(2):85-92.
110. Taninaga J, Nishiyama Y, Fujibayashi K, Gunji T, Sasabe N, Iijima K, et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: A case-control study. Sci Rep. 2019;9(1):12384.
111. Haba Y, Yano S, Akizuki H, Hashimoto T, Naito T, Hashiguchi N. Boerhaave syndrome due to excessive alcohol consumption: two case reports. Int J Emerg Med. 2020;13(1):56.
112. Hosoda T, Uehara Y, Kasuga T, Naito T. An HIV-infected patient with acute retinal necrosis as immune reconstitution inflammatory syndrome due to varicella-zoster virus. Aids. 2020;34(5):795-6.
113. Hosoda T, Uehara Y, Naito T. Were Additional Treatments Affecting Pharmacokinetics Administered after Raltegravir Overdosing?: Authors' Reply. Intern Med. 2020;59(10):1343.
114. Hosoda T, Uehara Y, Naito T. An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir. Intern Med. 2020;59(2):285-7.
115. Iriyama H, Abe T, Kushimoto S, Fujishima S, Ogura H, Shiraishi A, et al. Risk modifiers of acute respiratory distress syndrome in patients with non-pulmonary sepsis: a retrospective analysis of the FORECAST study. J Intensive Care. 2020;8:7.
116. Ishiguro M, Ueno Y, Ishiguro Y, Takanashi M, Murai K, Taieb G, et al. CD8(+) T-cell encephalitis mimicking PRES in AIDS: a case report. BMC Neurol. 2020;20(1):179.
117. Kaito S, Taniguchi Y, Kitamura A, Seino S, Amano H, Yokoyama Y, et al. Trajectories of kidney function and associated factors among community-dwelling older Japanese: a 16-year longitudinal study. Clin Exp Nephrol. 2020;24(4):330-8.
118. Komori A, Abe T, Kushimoto S, Ogura H, Shiraishi A, Saitoh D, et al. Characteristics and outcomes of bacteremia among ICU-admitted patients with severe sepsis. Sci Rep. 2020;10(1):2983.
119. Komori A, Abe T, Yamakawa K, Ogura H, Kushimoto S, Saitoh D, et al. Characteristics and outcomes of frail patients with suspected infection in intensive care units: a descriptive analysis from a multicenter cohort study. BMC Geriatr. 2020;20(1):485.
120. Miyagami T, Suyama Y, Takahashi Y, Yahagi Y, Harada M, Sugisaki N, et al. Anti-melanoma differentiation-associated gene 5 dermatomyositis and lung disease. QJM: An International Journal of Medicine. 2020;113(11):832-3.
121. Miyagami T, Suyama Y, Takahashi Y, Yang K-S, Naito T. Man With Thigh Pain. Annals of Emergency Medicine. 2020;75(2):305-8.
122. Miyagami T, Takahashi H, Murai K, Deshpande GA, Naito T. PET/CT, a useful approach to improving the diagnosis of large vessel vasculitis when conventional imaging fails. J Hosp Gen Med. 2020;2(3):78-84.
123. Miyagami T, Yokokawa H, Fujibayashi K, Fukuda H, Hisaoka T, Naito T. Assessing lifestyle-related diseases with body and muscle mass using bioelectrical impedance analysis. Osteoporos Sarcopenia. 2020;6(1):27-32.
124. Naito T, Suzuki M, Fujibayashi K, Kanazawa A, Takahashi H, Yokokawa H, et al. The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009-2018. J Infect Chemother. 2020;26(4):407-10.
125. Naito T, Suzuki M, Kanazawa A, Takahashi H, Fujibayashi K, Yokokawa H, et al. Pneumococcal vaccination reduces in-hospital mortality, length of stay and medical expenditure in hospitalized elderly patients. J Infect Chemother. 2020;26(7):715-21.
126. Suzuki M, Fukui Y, Saita M, Tanei M, Inui A, Naito T. Trend and cause of death of HIV-infected patients in Japan：A descriptive study using hospital admission records. J Hosp Gen Med. 2020;2:56-61.
127. Takahashi H, Yokomaku K, Tsukada K, Otsuka F, Morita H, Naito T. Educational program for general physicians to promote early diagnosis and initiation of treatment of human immune deficiency virus infection. J AIDS Res. 2020;22:46-50.
128. Yokokawa H, Fukuda H, Saita M, Miyagami T, Takahashi Y, Hisaoka T, et al. Serum zinc concentrations and characteristics of zinc deficiency/marginal deficiency among Japanese subjects. J Gen Fam Med. 2020;21(6):248-55.
129. Aoki N, Miyagami T, Shikino K, Yang KS, Naito T. Polymyalgia Rheumatica in a Patient with Pseudogout and Dementia. Am J Case Rep. 2021;22:e933926.
130. Chen Q, Tsubaki M, Minami Y, Fujibayashi K, Yumoto T, Kamei J, et al. Using Mobile Phone Data to Estimate the Relationship between Population Flow and Influenza Infection Pathways. Int J Environ Res Public Health. 2021;18(14):7439.
131. Du M, Hu W, Tamura T, Alshahni MM, Satoh K, Yamanishi C, et al. Investigation of the Physiological, Biochemical and Antifungal Susceptibility Properties of Candida auris. Mycopathologia. 2021;186(2):189-98.
132. Fukao Y, Nagasawa H, Nihei Y, Hiki M, Naito T, Kihara M, et al. COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. Clin Exp Nephrol. 2021;25(11):1240-6.
133. Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, et al. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep. 2021;11(1):8380.
134. Fukui S, Inui A, Nakanishi Y, Furusaka T, Saita M, Nakiri Y, et al. Inflammatory Findings of Blood Test：Comparison between Rheumatoid Arthritis andPolymyalgia Rheumatica in Departments of General Medicine. J Hosp Gen Med. 2021;3(3):71-8.
135. Fukui S, Kawamura W, Uehara Y, Naito T. A patient with psittacosis from a pigeon: A reminder of the importance of detailed interviews and relative bradycardia. IDCases. 2021;25:e01164.
136. Goto K, Yokokawa H, Fukuda H, Saita M, Hamada C, Hisaoka T, et al. An association between subcutaneous fat mass accumulation and hypertension. J Gen Fam Med. 2021;22(4):209-17.
137. Hayashi Y, Yokokawa H, Fukuda H, Saita M, Miyagami T, Takahashi Y, et al. Association between Visceral or Subcutaneous Fat Accumulation and B-Type Natriuretic Peptide among Japanese Subjects: A Cross-Sectional Study. J Clin Med. 2021;10(6):1315.
138. Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients. PLoS One. 2021;16(4):e0249449.
139. Ikeda N, Masubuchi H, Sato H, Nakashima S, Fujii T, Akashi S, et al. Clinical features and outcomes of a nosocomial outbreak of COVID-19 pneumonia associated with survival in hospitalized patients. J Hosp Gen Med. 2021;3(4):111-7.
140. Iriyama H, Komori A, Kainoh T, Kondo Y, Naito T, Abe T. A nested case-control study of risk for pulmonary embolism in the general trauma population using nationwide trauma registry data in Japan. Sci Rep. 2021;11(1):19192.
141. Iriyama H, Saita M, Yokomaku Y, Tsukada K, Naito T. Online-Learning Program for Japanese General Physicians to Promote an Appropriate Screening Test for Human Immunodeficiency Virus Infection. J Hosp Gen Med. 2021;3(4):118-23.
142. Kainoh T, Iriyama H, Komori A, Saitoh D, Naito T, Abe T. Risk Factors of Fat Embolism Syndrome After Trauma: A Nested Case-Control Study With the Use of a Nationwide Trauma Registry in Japan. Chest. 2021;159(3):1064-71.
143. Kogai T, Fujibayashi K, Yanagisawa N, Fukui N, Takahashi A, Naito T, et al. Impact on Diabetes Management Due to Social Participation Restrictions Associated with the COVID-19 Pandemic. Juntendo Medical Journal. 2021;67(4):333-7.
144. Komori A, Iriyama H, Aoki M, Deshpande GA, Saitoh D, Naito T, et al. Assessment of blood consumption score for pediatrics predicts transfusion requirements for children with trauma. Medicine (Baltimore). 2021;100(9):e25014.
145. Komori A, Iriyama H, Kainoh T, Aoki M, Naito T, Abe T. The impact of infection complications after trauma differs according to trauma severity. Sci Rep. 2021;11(1):13803.
146. Komori A, Mori H, Kojima Y, Tabe Y, Naito T. Preoperative Universal SARS-CoV-2 Screening for Asymptomatic Patients: A Report From Tokyo, Japan. J Cardiothorac Vasc Anesth. 2021;35(4):1265-7.
147. Komori A, Mori H, Naito T. The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan. Hum Vaccin Immunother. 2021;17(11):4673-4.
148. Kushiro S, Miyagami T, Kanai Y, Yang KS, Naito T. Delayed Diagnosis of Portal Vein Thrombosis Due to Premature Closure of Cholecystitis. Am J Med. 2021;134(11):e543-e5.
149. Matsushita Y, Kusaoi M, Hiki M, Murayama G, Abe Y, Nozawa K, et al. Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A retrospective observational study. Ther Apher Dial. 2021;25(4):390-400.
150. Miyagami T, Harada T, Terukina H, Komori A, Watari T, Shimizu T, et al. Diagnostic Difficulties in Treating a Typical Case of a Patient Being a Doctor. Am J Med. 2021;134(1):52-3.
151. Miyagami T, Takada A, Shimizu T, Naito T. Delayed diagnosis of a piriformis abscess due to hyposkillia and communication error. BMJ Case Rep. 2021;14(8):e242088.
152. Miyagami T, Uehara Y, Harada T, Watari T, Shimizu T, Nakamura A, et al. Delayed treatment of bacteremia during the COVID-19 pandemic. Diagnosis (Berl). 2021;8(3):327-32.
153. Naito T, Endo K, Fukushima S, Suzuki M, Fukui Y, Saita M, et al. A preliminary analysis of the performance of a targeted HIV electronic medical records alert system: A single hospital experience. J Infect Chemother. 2021;27(1):123-5.
154. Okamoto A, Yokokawa H, Nagamine T, Fukuda H, Hisaoka T, Naito T. Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists. J Diabetes Metab Disord. 2021;20(2):2121-8.
155. Saito K, Ai T, Kawai A, Matsui J, Fukushima Y, Kikukawa N, et al. Performance and usefulness of a novel automated immunoassay HISCL SARS-CoV-2 Antigen assay kit for the diagnosis of COVID-19. Sci Rep. 2021;11(1):23196.
156. Sasano H, Yoshizawa T, Kawakami T, Takahashi T, Suzuki M, Fukui Y, et al. Improvements in Quality Indicators for the Treatment of Infectious Diseases with Intervention by an Antimicrobial Stewardship Team. J Hosp Gen Med. 2021;3(1):1-10.
157. Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, et al. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. PLoS One. 2021;16(2):e0246536.
158. Yan Y, Naito T, Hsu NC, Shin DH, Kang HJ, Vidyarthi AR, et al. Adoption of Hospitalist Care in Asia: Experiences From Singapore, Taiwan, Korea, and Japan. J Hosp Med. 2021;16(7):443-5.
159. Yano S, Fukui S, Inui A, Naito T. Cavitary pulmonary Kaposi's sarcoma in AIDS. IDCases. 2021;24:e01162.
160. Yokokawa H, Fukuda H, Saita M, Goto K, Kaku T, Miyagami T, et al. An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects. Diabetol Metab Syndr. 2021;13(1):44.
161. Arikawa M, Takahashi Y, Kano N, Yamada K, Ando J, Ochiai T, et al. Bilateral Adrenal Primary Malignant Lymphoma with Inappropriate Secretion of Antidiuretic Hormone. J Hosp Gen Med. 2022;4(4):178-83.
162. Fujisawa T, Fukuda H, Sakamoto N, Hojo M, Tomishima K, Ishii S, et al. Relief Effect of Carbon Dioxide Insufflation in Transnasal Endoscopy for Health Checks-A Prospective, Double-Blind, Case-Control Trial. J Clin Med. 2022;11(5).
163. Fukui S, Inui A, Saita M, Kobayashi D, Naito T. Comparison of the clinical parameters of patients with COVID-19 and influenza using blood test data: a retrospective cross-sectional survey. J Int Med Res. 2022;50(2):3000605221083751.
164. Fukui S, Inui A, Saita M, Kobayashi D, Naito T. Clinical prediction rule for bacteremia with pyelonephritis and hospitalization judgment: chi-square automatic interaction detector (CHAID) decision tree analysis model. J Int Med Res. 2022;50(1):3000605211065658.
165. Fukui S, Kobayashi D, Inui A, Katahira T, Komatsu R, Sugita M, et al. Clinical prediction rules for COVID-19: Using a Chi-squared automatic interaction detector (CHAID) decision tree analysis model. J Hosp Gen Med. 2022;4(3):125-43.
166. Fukui S, Kushiro S, Kano N, Yamamoto Y, Furusaka T, Aoki N, et al. Streptococcus bovis as a cause of uncontrollable colon bleeding. IDCases. 2022;29:e01547.
167. Fukushima T, Chubachi S, Namkoong H, Asakura T, Tanaka H, Lee H, et al. Clinical significance of pre-diabetes, undiagnosed diabetes, and diagnosed diabetes on clinical outcomes in COVID-19: Integrative analysis from the Japan COVID-19 Task Force. Diabetes Obes Metab. 2022.
168. Furusaka T, Miyagami T, Suzuki M, Naito T. Uncommon presentation of Kikuchi disease. Clin Case Rep. 2022;10(4):e05673.
169. Furuya S, Fukui S, Maekawa Y, Aoki N, Inui A, Naito T. Paragonimus westermani as a cause of Löeffler's syndrome. IDCases. 2022;27:e01427.
170. Gohda T, Murakoshi M, Suzuki Y, Hiki M, Naito T, Takahashi K, et al. Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients. PLoS One. 2022;17(10):e0275745.
171. Haba Y, Akizuki H, Hashiguchi N, Naito T. Hypoprothrombinemia During Cefmetazole Treatment: A Case Report. Am J Case Rep. 2022;23:e936712.
172. Haba Y, Naito T. Psittacosis with a reversed halo sign. Indian J Med Res. 2022.
173. Haba Y, Naito T. Pneumomediastinum in a cheerleading student. Clin Case Rep. 2022;10(7):e6053.
174. Haba Y, Naito T. Acrocyanosis Secondary to Esophageal Cancer. J Gen Intern Med. 2022.
175. Hasegawa T, Hato T, Okayama T, Ikeo K, Miyamoto Y, Iwanaga N, et al. Th1 cytokine endotype discriminates and predicts severe complications in COVID-19. Eur Cytokine Netw. 2022;33(2):1-12.
176. Heissig B, Salama Y, Iakoubov R, Vehreschild JJ, Rios R, Nogueira T, et al. COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity. Biomedicines. 2022;10(10).
177. Hisamatsu D, Ikeda A, Ito L, Matsushita Y, Hiki M, Mori H, et al. Longitudinal Analyses after COVID-19 Recovery or Prolonged Infection Reveal Unique Immunological Signatures after Repeated Vaccinations. Vaccines (Basel). 2022;10(11).
178. Honjo S, Miyagami T, Suzuki M, Ito A, Naito T. Rare presentation of emphysematous pyelonephritis due to faulty catheter insertion. Clin Case Rep. 2022;10(8):e6251.
179. Igawa G, Ai T, Yamamoto T, Ito K, Nojiri S, Saito K, et al. Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo. Sci Rep. 2022;12(1):8707.
180. Jimbo H, Horimoto Y, Hiki M, Tabe Y, Watanabe J, Saito M, et al. Successful treatment with steroid pulse therapy for a COVID-19 case with progressive respiratory failure during treatment for pleural metastasis of breast cancer. Surg Case Rep. 2022;8(1):96.
181. Kagiyama N, Komatsu T, Nishikawa M, Hiki M, Kobayashi M, Matsuzawa W, et al. Impact of a telemedicine system on work burden and mental health of healthcare providers working with COVID-19: a multicenter pre-post prospective study. JAMIA Open. 2022;5(2):ooac037.
182. Kano N, Fukui S, Kushiro S, Inui A, Saita M, Kura Y, et al. Basophilic stippling in red blood cells in the bone marrow: indication for lead poisoning diagnosis. J Int Med Res. 2022;50(2):3000605221078405.
183. Komori A, Mori H, Naito T. The impact of the COVID-19 pandemic on other infections differs by their route of transmission: A retrospective, observational study in Japan. J Infect Chemother. 2022;28(12):1700-3.
184. Miyagami T, Kushiro S, Arikawa M, Murakami K, Naito T. A Case of Infective Endocarditis Associated With Patent Ductus Arteriosus in Which PET/CT Was Useful for Diagnosis. Clin Nucl Med. 2022;47(9):832-3.
185. Miyagami T, Nakayama I, Naito T. What Causes Diagnostic Errors? Referred Patients and Our Own Cognitive Biases: A Case Report. Am J Case Rep. 2022;23:e935163.
186. Miyagami T, Yamada T, Kanzawa Y, Kosugi S, Nagasaki K, Nagano H, et al. Large-Scale Observational Study on the Current Status and Challenges of General Medicine in Japan: Job Description and Required Skills. Int J Gen Med. 2022;15:975-84.
187. Mori H, Naito T. A rapid increase in the COVID-19 vaccination rate during the Olympic and Paralympic Games 2021 in Japan. Hum Vaccin Immunother. 2022;18(1):2010440.
188. Naito T. Will the Introduction of the Hospitalist System Save Japan? Intern Med. 2022.
189. Naito T, Fujibayashi K, Mori H, Fukushima S, Yuda M, Fukui N, et al. Delayed diagnosis of human immunodeficiency virus infection in people diagnosed with syphilis: A nationwide cohort study from 2011 to 2018 in Japan. J Infect Chemother. 2022;28(2):333-5.
190. Naito T, Mori H, Fujibayashi K, Fukushima S, Yuda M, Fukui N, et al. Syphilis in people living with HIV does not account for the syphilis resurgence in Japan. J Infect Chemother. 2022.
191. Naito T, Mori H, Fujibayashi K, Fukushima S, Yuda M, Fukui N, et al. Analysis of antiretroviral therapy switch rate and switching pattern for people living with HIV from a national database in Japan. Sci Rep. 2022;12(1):1732.
192. Naito T, Suzuki M, Fukushima S, Yuda M, Fukui N, Tsukamoto S, et al. Comorbidities and co-medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan. HIV Med. 2022;23(5):485-93.
193. Naito T, Tsuchida N, Kusunoki S, Kaneko Y, Tobita M, Hori S, et al. Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study. Expert Rev Vaccines. 2022:1-11.
194. Naito T, Yan Y, Tabe Y, Seyama K, Deshpande GA. Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan. Hum Vaccin Immunother. 2022;18(1):1-2.
195. Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022.
196. Nishida Y, Mita T, Hiki M, Matsushita Y, Naito T, Watada H. Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in Japan. Diabetes Ther. 2022;13(2):325-39.
197. Nishiyama M, Osawa K, Nakamura A, Kawakami T, Chonan M, Misawa S, et al. The 24-h reporting of Gram stains from positive blood cultures contributes to physician's use of appropriate antimicrobials: Experience at a university hospital. J Infect Chemother. 2022;28(6):836-9.
198. Nojiri S, Irie Y, Kanamori R, Naito T, Nishizaki Y. Mortality Prediction of COVID-19 in Hospitalized Patients Using the 2020 Diagnosis Procedure Combination Administrative Database of Japan. Intern Med. 2022.
199. Prasertbun R, Mori H, Mahittikorn A, Siri S, Naito T. Pneumonia, influenza, and dengue cases decreased after the COVID-19 pandemic in Thailand. Trop Med Health. 2022;50(1):27.
200. Saita M, Yan Y, Ito K, Sasano H, Seyama K, Naito T. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan. J Infect Chemother. 2022;28(1):116-9.
201. Sasano H, Yoshizawa T, Suzuki M, Fukui Y, Arakawa R, Tamura N, et al. A Case of Persistent Bacillus cereus Bacteremia Responding to a Combination of Vancomycin and Gentamicin. Case Rep Infect Dis. 2022;2022:8725102.
202. Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, et al. Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies. Sci Rep. 2022;12(1):14909.
203. Takei S, Ai T, Yamamoto T, Igawa G, Kanno T, Tobiume M, et al. Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment. PLoS One. 2022;17(9):e0274181.
204. Tsuchiya K, Hosaka Y, Takahashi T, Chonan M, Makita Y, Katayama I, et al. Meals and Room Temperature Storage do not Significantly Affect Feasibility of Direct RT-PCR Tests for SARS-CoV-2 Using Saliva. Clin Lab. 2022;68(6).
205. Tsuchiya K, Yamamoto N, Hosaka Y, Wakita M, Hiki M, Matsushita Y, et al. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity. Front Microbiol. 2022;13:912061.
206. Wang QS, Edahiro R, Namkoong H, Hasegawa T, Shirai Y, Sonehara K, et al. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. Nat Commun. 2022;13(1):4830.
207. Wang X, Schmerold L, Naito T. Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan. J Infect Chemother. 2022.
208. Yan Y, Naito T, Tabe Y, Ito K, Nojiri S, Deshpande GA, et al. Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan. Vaccine. 2022;40(23):3103-8.
209. Yan Y, Tomooka K, Naito T, Tanigawa T. Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: A large multicenter study in Japan. J Infect Chemother. 2022;28(5):709-13.
210. Yokokawa H, Suzuki M, Aoki N, Sato Y, Naito T. Achievement of target blood pressure among community residents with hypertension and factors associated with therapeutic failure in the northern territory of Japan. J Int Med Res. 2022;50(10):3000605221126878.

著書

• 1. 不明熱診療マニュアル、医学図書出版、2009/3

• 2. 原因不明の胸痛診断ガイドブック（パーフェクト総合診療医１）、出版社：エクスナレッジ 、2010/12/24

• 3. 原因不明の胸痛診断ガイドブック（パーフェクト総合診療医2）、出版社：エクスナレッジ 、2012/10/2

• 4. もう迷わない！原因不明の発熱はこう診断する、出版社：エクスナレッジ、2012/12

• 5. 身体所見のメカニズムA　to Z ハンドブック（Student　Consult）2019/12